Amol Mehta, MD

276 posts

Amol Mehta, MD banner
Amol Mehta, MD

Amol Mehta, MD

@AmolMehtaMD

Neuroendovascular Surgery Fellow @MountSinai former @Columbianeuron Interested in: Neurointervention, Stroke, Public Health, Jazz Saxophone

Katılım Eylül 2012
347 Takip Edilen383 Takipçiler
Amol Mehta, MD retweetledi
NEJM
NEJM@NEJM·
Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: nejm.org/doi/full/10.10… Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.10…
NEJM tweet media
English
16
310
717
462K
Amol Mehta, MD retweetledi
NEJM
NEJM@NEJM·
A 7-year-old boy was brought to a hospital with a 3-month history of cognitive deterioration and seizures. He had contracted measles at 7 months of age while living in an area where the infection is endemic. Read the full case details in the Images in Clinical Medicine article “Subacute Sclerosing Panencephalitis after Measles Infection,” from Children’s Hospital of Orange County (@chocchildrens) and University of California, Irvine (@UCIrvine): nej.md/4qY4Ihk
NEJM tweet media
English
1
35
130
16.5K
Amol Mehta, MD retweetledi
Stephan A Mayer
Stephan A Mayer@stephanamayer·
Lowering BP excessively (SBP <140) after thrombectomy worsens outcome. This effect is even more pronounced when ischemic leukopathy is present, likely due to impaired autoregulation. ahajournals.org/doi/abs/10.116…
English
0
20
39
3K
Amol Mehta, MD retweetledi
JNIS
JNIS@JNIS_BMJ·
🧠 In a prospective multicenter study of 66 patients with NPH, transvenous eShunt placement showed no device-related SAEs at 90 days and significant improvements in gait, cognition, and urinary symptoms. 🔗 Read more: bit.ly/4az2ZtQ
English
1
49
168
11.5K
Amol Mehta, MD
Amol Mehta, MD@AmolMehtaMD·
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial - The Lancet thelancet.com/journals/lance…
English
0
1
8
426
Amol Mehta, MD retweetledi
JAMA Neurology
JAMA Neurology@JAMANeuro·
Among patients <70 years with acute #BasilarArteryOcclusion, endovascular thrombectomy doubled the rate of ambulatory and self-care capable outcomes at 3 years vs medical treatment. bit.ly/4qkTeE9
JAMA Neurology tweet media
English
3
15
47
3.5K
Amol Mehta, MD retweetledi
AHA Science
AHA Science@AHAScience·
CHOICE2 results presented at #ISC26
AHA Science tweet media
English
0
26
77
6.4K
Amol Mehta, MD
Amol Mehta, MD@AmolMehtaMD·
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial - The Lancet thelancet.com/journals/lance…
English
0
0
13
1.7K
Amol Mehta, MD retweetledi
AshuJadhav
AshuJadhav@AshuPJadhav·
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion | New England Journal of Medicine nejm.org/doi/full/10.10…
English
0
16
66
8.5K
Amol Mehta, MD retweetledi
Shadi Yaghi
Shadi Yaghi@ShadiYaghi2·
The new AHA acute stroke guidelines are out. These reflect comprehensive available evidence in acute ischemic stroke including systems of care, use of TNK, EVT eligibility, antithrombotic use, pediatric stroke, and management of cytotoxic brain edema. ahajournals.org/doi/10.1161/ST…
English
4
94
264
32.5K
Amol Mehta, MD retweetledi
Stroke AHA/ASA
Stroke AHA/ASA@StrokeAHA_ASA·
In an individual participant data meta-analysis of RCTs, acute carotid stenting during EVT was associated with better functional outcomes than delayed carotid stenting, and prior IVT treatment did not modify this. #stroke ahajrnls.org/49KE2LU
Stroke AHA/ASA tweet media
English
2
29
66
7.1K
Amol Mehta, MD
Amol Mehta, MD@AmolMehtaMD·
Large core EVT decision making can be challenging for patients and families. Grateful to @ShashvatDesai @AshuPJadhav @mdgoels and Scott brown with their help in developing a visual aid to hopefully make these decisions a bit easier.
Amol Mehta, MD tweet media
AshuJadhav@AshuPJadhav

Visual Tools for Informed Decision-Making in Large-Core Thrombectomy for Acute Ischemic Stroke | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… @SVINJournal @svinsociety @StrokeAHA_ASA

English
0
2
14
1.1K
Amol Mehta, MD retweetledi
Shadi Yaghi
Shadi Yaghi@ShadiYaghi2·
The TRIMIS trial presented at WSC showed a benefit in patients with NIHSS 0-5 and a proximal LVO (M1 and ICA). One in five patients treated medically deteriorated and required rescue EVT. #EVTFORALLELVO @NAsdaghi @almuftifawaz @eytanraz
World Stroke Academy@WorldStrokeEd

#MondayTip 🧠 🙅‍♂️Low NIHSS (0–5) ≠ mild stroke when LVO is present ❌EVT decisions ≠ NIHSS cutoffs alone 🗣️Prioritize disabling symptoms (aphasia,vision loss) ⚠️Assess END risk and imaging🩻 👤Incorporate patient values 💬, until RCT data arrive ⏳ doi.org/10.5853/jos.20…

English
1
28
100
9.4K
Amol Mehta, MD
Amol Mehta, MD@AmolMehtaMD·
Very challenging case from earlier in the year. Thank you to @TheAJNR for publishing our experience. The “Stentriever Sandwich” Technique: Management of Stent Retriever Entrapment after Carotid Stenting in Tandem Stroke ajnr.org/content/early/…
English
0
0
8
427
Amol Mehta, MD retweetledi
JAMA Neurology
JAMA Neurology@JAMANeuro·
Editorial: Tofersen slowed functional decline and reduced risk of death for patients with SOD1-related #ALS, especially with early treatment, and showed durable biomarker improvements over 148 weeks. ja.ma/3Lcagpy
JAMA Neurology tweet media
English
2
14
34
3.8K